Victory Capital Management Inc. Sells 516,941 Shares of Unum Group (NYSE:UNM)

Victory Capital Management Inc. trimmed its position in Unum Group (NYSE:UNM - Free Report) by 44.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 654,153 shares of the financial services provider's stock after selling 516,941 shares during the quarter. Victory Capital Management Inc. owned approximately 0.34% of Unum Group worth $29,581,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Silver Oak Securities Incorporated acquired a new stake in shares of Unum Group during the 3rd quarter worth approximately $25,000. Contravisory Investment Management Inc. bought a new position in Unum Group in the fourth quarter valued at approximately $25,000. Neo Ivy Capital Management acquired a new stake in Unum Group during the 3rd quarter worth $36,000. Daiwa Securities Group Inc. bought a new stake in shares of Unum Group during the 4th quarter valued at $36,000. Finally, CVA Family Office LLC acquired a new position in shares of Unum Group in the 4th quarter valued at $49,000. 86.57% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms recently commented on UNM. Morgan Stanley upped their price objective on Unum Group from $50.00 to $52.00 and gave the company an "equal weight" rating in a report on Monday, April 15th. Wells Fargo & Company increased their price target on shares of Unum Group from $64.00 to $66.00 and gave the company an "overweight" rating in a research report on Thursday, April 11th. StockNews.com raised shares of Unum Group from a "hold" rating to a "buy" rating in a research note on Wednesday, January 31st. JPMorgan Chase & Co. upped their target price on shares of Unum Group from $56.00 to $58.00 and gave the company an "overweight" rating in a research note on Tuesday, April 2nd. Finally, Truist Financial lifted their price target on shares of Unum Group from $57.00 to $62.00 and gave the stock a "buy" rating in a research report on Thursday, May 2nd. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, Unum Group presently has an average rating of "Moderate Buy" and an average target price of $57.38.

Insiders Place Their Bets

In other news, CFO Steven Andrew Zabel sold 10,000 shares of the business's stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $51.06, for a total value of $510,600.00. Following the sale, the chief financial officer now owns 122,246 shares of the company's stock, valued at $6,241,880.76. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other Unum Group news, EVP Elizabeth Claire Ahmed sold 5,000 shares of the firm's stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $50.00, for a total value of $250,000.00. Following the completion of the transaction, the executive vice president now directly owns 55,450 shares in the company, valued at $2,772,500. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Steven Andrew Zabel sold 10,000 shares of the business's stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $51.06, for a total value of $510,600.00. Following the transaction, the chief financial officer now directly owns 122,246 shares in the company, valued at approximately $6,241,880.76. The disclosure for this sale can be found here. Insiders sold a total of 81,000 shares of company stock valued at $4,018,100 in the last quarter. 0.93% of the stock is currently owned by insiders.

Unum Group Stock Up 0.2 %

UNM traded up $0.11 during trading on Wednesday, reaching $52.58. The company had a trading volume of 848,350 shares, compared to its average volume of 1,387,857. The business's fifty day moving average price is $51.68 and its 200 day moving average price is $47.71. The company has a debt-to-equity ratio of 0.34, a current ratio of 0.28 and a quick ratio of 0.28. Unum Group has a 12 month low of $41.75 and a 12 month high of $54.57. The company has a market cap of $9.96 billion, a P/E ratio of 7.81, a PEG ratio of 1.28 and a beta of 0.87.

Unum Group (NYSE:UNM - Get Free Report) last announced its earnings results on Tuesday, April 30th. The financial services provider reported $2.12 earnings per share for the quarter, topping analysts' consensus estimates of $1.97 by $0.15. The firm had revenue of $3.20 billion during the quarter, compared to analyst estimates of $3.20 billion. Unum Group had a net margin of 10.52% and a return on equity of 16.02%. The company's revenue for the quarter was up 5.4% compared to the same quarter last year. During the same period in the prior year, the business earned $1.87 EPS. Equities analysts anticipate that Unum Group will post 8.19 EPS for the current year.

Unum Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 17th. Shareholders of record on Friday, April 26th will be paid a $0.365 dividend. This represents a $1.46 annualized dividend and a yield of 2.78%. The ex-dividend date of this dividend is Thursday, April 25th. Unum Group's payout ratio is 21.69%.

Unum Group Company Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.